Top Sell
| Security | Buy | Sell | Buy (1M) | Sell (1M) ▼ | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Minerva Neurosciences Inc. | 0 | 13 | 0 | 3 | €2.50 | - | - |
| Trevena Inc. | 2 | 26 | 0 | 3 | €0.15 | €6.48 | 4136.601% |
| Moleculin Biotech Inc | 3 | 26 | 0 | 3 | €0.41 | €18.42 | 4393.659% |
| Cyclacel Pharmaceuticals Inc. | 2 | 10 | 0 | 2 | €0.22 | €14.66 | 6565.591% |
| Glycomimetics Inc. | 3 | 9 | 0 | 2 | €0.14 | €9.13 | 6278.911% |
| AEterna Zentaris Inc. | 2 | 22 | 0 | 2 | €1.87 | €8.51 | 355.096% |
| Vivoryon Therapeutics N.V. | 1 | 3 | 0 | 2 | €2.38 | - | - |
| Evoke Pharma Inc. | 0 | 24 | 0 | 1 | €0.37 | - | - |
| Inventiva SA | 1 | 1 | 0 | 1 | €1.63 | €6.00 | 267.197% |
| Adocia | 0 | 1 | 0 | 1 | €5.55 | - | - |
| Cara Therapeutics Inc. | 10 | 8 | 0 | 1 | €0.21 | €4.61 | 2089.184% |
| Cellectar BioSciences Inc. | 4 | 5 | 0 | 1 | €1.99 | €14.75 | 641.347% |
| Organovo Holdings Inc. | 0 | 10 | 0 | 1 | €0.42 | - | - |
| Neurocrine Bioscience | 41 | 1 | 2 | 1 | €103.40 | €155.89 | 50.764% |
| Alterity Therapeutics Ltd. ADR | 0 | 1 | 0 | 0 | €1.00 | - | - |
| Atara Biotherapeutics Inc. | 1 | 2 | 0 | 0 | €0.37 | - | - |
| Indivior plc | 0 | 2 | 0 | 0 | €9.10 | €6.00 | -34.066% |
| Inotiv Inc. | 4 | 1 | 1 | 0 | €1.71 | €9.93 | 480.602% |
| Coherus Bioscien. | 1 | 2 | 1 | 0 | €0.95 | - | - |
| Salarius Pharmaceuticals Inc. | 0 | 1 | 0 | 0 | €0.39 | - | - |
| Corbus Pharmaceuticals Holding Inc. | 1 | 1 | 0 | 0 | €17.90 | €50.00 | 179.330% |
| Fibrogen Inc. | 0 | 1 | 0 | 0 | €0.35 | - | - |
| Sage Therapeutics Inc. | 5 | 2 | 0 | 0 | €6.31 | €23.82 | 277.405% |
| BioLine RX Ltd ADR | 0 | 1 | 0 | 0 | €0.46 | - | - |
| Shin Nippon Biomedical Laboratories Ltd. | 0 | 1 | 0 | 0 | €7.55 | - | - |